ArticleJournal of nanobiotechnology2024

Zinc-based radioenhancers to activate tumor radioimmunotherapy by PD-L1 and cGAS-STING pathway.

Mengjiao Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.